Selected engagements

  • 01
    Adapting ICER to transformative medicines
    Our client is a global pharma company and is interested to understand the implications of the 2019/2020 updates to the ICER Value Assessment Framework...
    View engagement
  • 02
    EU Orphan Medicines Regulation Review
    The purpose of the project was to delver an external report that evaluates the broader economic and societal impact of the Orphan Medicine Product (OMP)...
    View engagement


Get In Touch